INS and Hyperglycemia: Finally, there was no difference between time of intervention for hyperglycemia (12.3 ± 1.6 vs. 12.6 ± 3.1 weeks, P = 0.628), glycemic control (FBG 4.39 ± 0.23 vs. 4.66 ± 0.33 mmol/L, P = 0.912; 1 h BG 7.14 ± 1.23 vs. 7.61 ± 1.09 mmol/L, P = 0.175; 2 h BG 6.98 ± 1.31 vs. 6.79 ± 1.22 mmol/L, P = 0.614 and HbA1c 5.2 ± 0.6 vs. 5.4 ± 0.4 %, P = 0.566 at delivery), delivery mode, preterm, newborn weight, or incidence of macrosomia between women with insulin and without (Table 1).